The Acceptance, Safety, and Efficacy of MadaJet Versus Needle Injection for Sperm Retrieval in Patients With Azoospermia
1 other identifier
interventional
60
1 country
1
Brief Summary
To compare the acceptance, safety, and efficacy of needle-free jet anaesthetic technique (MadaJet) versus needle injection for sperm retrieval in patients with azoospermia.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jul 2017
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 2, 2017
CompletedFirst Posted
Study publicly available on registry
June 8, 2017
CompletedStudy Start
First participant enrolled
July 15, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 25, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
December 25, 2017
CompletedJanuary 2, 2018
December 1, 2017
5 months
June 2, 2017
December 29, 2017
Conditions
Outcome Measures
Primary Outcomes (1)
Pain score
Right after completing the injection, information about the pain before, during and after the sperm retrieval technique will be immediately documented by the visual analog scale (VAS) questionnaire on 10 cm lines (0 represents no pain, whereas 10 marks the highest score).
1 year
Secondary Outcomes (9)
Pressure (fear) of the patients
1 year
Discomfort of the patients
1 year
Incidence of treatment (Bleeding)
1 year
Incidence of treatment (Swelling)
1 year
Incidence of treatment (Hematoma)
1 year
- +4 more secondary outcomes
Study Arms (2)
MadaJet
EXPERIMENTALJet injector (Madajet medical Urology) preloaded as manufacturer's instruction
Needle injection
EXPERIMENTAL01 sterile 10-mL syringe with small gauge needle (25 ga), solution for sterile preparation, 10 - 15 mL Lidocaine 2%
Interventions
The spermatic cord is firmly trapped between the middle finger, index finger and thumb of the left hand. The injector's sheath is placed over the spermatic cord with gentle pressure adjacent to the external inguinal ring. Depending upon the thickness of spermatic cord, three or four injections are consecutively administered around it, beginning from proximal to distal points.
The pubic tubercle is palpated on the side that is going to be blocked. The spermatic cord is then immobilised with the non-dominant hand between the thumb and index finger. Right after needle puncture with attached syringe and local anaesthetic solution is conducted at a point that is 1 cm inferior to and 1 cm medial to the pubic tubercle, pass the needle directly downward in a vertical fashion, which leads it into the spermatic cord. After a check-up (negative aspiration) for bleeding, approximately 3 mL of solution (Lidocaine 2%) is injected into the cord.
Eligibility Criteria
You may qualify if:
- Patients (including obstructive azoospermia and non-obstructive azoospermia) in need of sperm retrieval (PESA, TESE) for ICSI.
You may not qualify if:
- Have not finished the process of sperm retrieval techniques.
- Malformation of genital organs (e.g. spermatic cord, testicle)
- Anxious, alcoholic patients.
- Patients giving a history of personality disorders.
- Patients who abuse drugs.
- Disagree to participate in the study.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
My Duc Hospital
Ho Chi Minh City, 84, Vietnam
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Khoa D Le, Dr
Mỹ Đức Hospital
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Director
Study Record Dates
First Submitted
June 2, 2017
First Posted
June 8, 2017
Study Start
July 15, 2017
Primary Completion
December 25, 2017
Study Completion
December 25, 2017
Last Updated
January 2, 2018
Record last verified: 2017-12
Data Sharing
- IPD Sharing
- Will not share